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ABSTRACT
Emergency radiological diagnosis of acute ischaemic stroke requires the accurate detection and 
appropriate interpretation of relevant imaging findings. Non-contrast computed tomography (CT) provides 
fast and low-cost assessment of the early signs of ischaemia and is the most widely used diagnostic 
modality for acute stroke. The Alberta Stroke Program Early CT Score (ASPECTS) is a quantitative and 
clinically validated method to measure the extent of ischaemic signs on brain CT scans. The CE-marked 
electronic-ASPECTS (e-ASPECTS) software automates the ASPECTS score. Anglia Ruskin Clinical 
Trials Unit (ARCTU) independently carried out a clinical investigation of the e-ASPECTS software, an 
automated scoring system which can be integrated into the diagnostic pathway of an acute ischaemic 
stroke patient, thereby assisting the physician with expert interpretation of the brain CT scan. Here we 
describe a literature review of the clinical importance of reliable assessment of early ischaemic signs on 
plain CT scans, and of technologies automating these processed scoring systems in ischaemic stroke 
on CT scans focusing on the e-ASPECTS software. To be suitable for critical appraisal in this evaluation, 
the published studies needed a sample size of a minimum of 10 cases. All randomised studies were 
screened and data deemed relevant to demonstration of performance of ASPECTS were appraised. 
The literature review focused on three domains: i) interpretation of brain CT scans of stroke patients, ii) 
the application of the ASPECTS score in ischaemic stroke, and iii) automation of brain CT analysis. 
Finally, the appraised references are discussed in the context of the clinical impact of e-ASPECTS and 
the expected performance, which will be independently evaluated by a non-inferiority study conducted 
by the ARCTU.
Keywords: Ischaemic stroke, Alberta Stroke Program Early CT Score (ASPECTS), e-ASPECTS, automated, 
computed tomography, patient selection.
INTRODUCTION
Stroke is a devastating disease with a paramount 
associated social and healthcare cost. In Europe 
stroke is the second leading cause of mortality, with 
nearly 1.3 million deaths each year, and the primary 
cause of disability resulting in long-term residential 
care. On average, 0.27% of gross domestic product 
is spent on stroke by national health systems 
internationally.1 An ischaemic stroke occurs when 
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a blood vessel in the brain becomes blocked by a 
blood clot or an embolus. This prevents oxygen 
and nutrients from reaching nerve cells in the 
affected area of the brain. These nerve cells can 
die within minutes and the area of the body that 
they control may cease to function. This damage 
can be permanent, especially if the patient is not 
immediately treated. 
Patients who have experienced a stroke will most 
likely be taken to a nearby hospital. Upon arriving 
at the hospital, medical staff will attempt to treat 
the patient, considering the clinical presentation 
together with information obtained from an 
emergency non-contrast computed tomography 
(CT) scan of the patient’s brain.2 The focus of 
immediate care for patients who have suffered a 
stroke is to re-establish blood flow (reperfusion) to 
the brain either by
• thrombolysis, administered within 4.5 hours 
from symptom onset with recombinant tissue 
plasminogen activator (rt-PA)
• endovascular treatment with stent-retrievers or 
aspiration within 8 hours, or
• a combination of both (bridging)
THE DIFFICULTY IN DETECTING EARLY
ISCHAEMIC DAMAGE ON BRAIN 
NON-CONTRAST COMPUTED
TOMOGRAPHY SCANS
Eligibility for stroke treatment depends not only 
upon time from stroke onset, but also on the extent 
of ischaemic damage on CT scans. Changes on the 
CT scan denote predominately irreversibly infarcted 
tissue that appears hypodense, representing 
the infarct core. In the first 6 hours following 
stroke onset, stroke detection is challenging3 and 
requires significant expertise, as only subtle signs 
of cerebral ischaemia are present on CT. These 
include hyperdense artery sign, the insularribbon 
sign, obscuration of the lentiform nucleus, blurring 
of grey—white matter differentiation, and sulcal 
effacement.4 Even amongst experts quantification 
of these signs remains highly reader dependent with 
significant inter and intra-reader variability.5-7 
Kunst et al.8 describe that detection of signs of 
early ischaemia on non-contrast CT is influenced 
by several factors. These include the severity of 
the infarct, as measured by clinical examination 
and National Institutes of Health Stroke Scale 
(NIHSS), and the time between symptom onset and 
imaging. The studies that the authors reviewed 
demonstrated that the detection rate for signs of 
early ischaemia within the 3-hour time window 
is 67% or less in most trials, and may be as low as 
31%. At 6 hours the rate of detection increased 
to approximately 82%, but this is outside the 
therapeutic window for intravenous (IV) rt-PA. 
Lack of Experts
A consultant neuroradiologist should ideally carry 
out proper assessment of the patients’ CT scans. 
However, many hospitals in the UK and around 
the world do not have 24/7 access to an expert 
neuroradiologist. Therefore, they are unable to 
provide an optimal stroke service as they inevitably 
rely on non-expert interpretation of CT scans 
during the therapeutic time window. 
Inter-Reader Variability
There is discussion on the inter-reader variability 
in quantifying the extent of infarction. Even 
experienced clinicians show only 39% agreement 
in identifying if ischaemic changes on non-contrast 
CT involve greater than one-third of the middle 
cerebral artery (MCA) territory.5 Mullins et al.9 
conducted a systematic review of CT scan 
interpretation by visual inspection of the scan. 
It highlighted the general lack of definitions 
for early infarction signs. Investigators in a 
substantial proportion of the studies did not 
define the infarction signs they sought. Looking 
at the literature it becomes clear that a 
standardised evaluation method is needed in acute 
ischaemic stroke.10-13 
THE DEVELOPMENT OF THE
ASPECTS SCORE
The European Cooperative Acute Stroke Study 
(ECASS) pioneered the importance of assessing 
early ischaemic changes (EIC) to predict benefit 
from thrombolysis and introduced the ‘one-third’ 
rule.8 A post-hoc analysis suggested that the 
extent of EIC is an important predictor of the 
response to IV thrombolysis.3 Increased risk of 
symptomatic intracranial haemorrhage (sICH) was 
confirmed in secondary analysis of the ECASS-2 
CT scans.14 Given the difficulties with the reliability 
of the one-third MCA rule15 the Calgary Stroke 
Program developed the Alberta Stroke Program 
Early CT Score (ASPECTS) as a systematic 
approach to assessing EIC on non-contrast CT.16 
ASPECTS enables a quantitative evaluation of 
early ischaemic changes in the MCA territory. 
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The overall inter-observer agreement of ASPECTS 
seems good compared with that of the one-third 
MCA rule and provides a systematic method to 
analyse head CT scans. Clinician agreement was 
shown to be superior to that of the one-third 
MCA rule.10
ASPECTS is a topographic scoring system that 
divides the brain hemisphere affected by stroke 
into ten regions of interest. Areas are weighted 
according to functional importance with equal 
weighting given to smaller structures and larger 
cortical areas. The score is calculated from 
evaluation of two standardised levels of the 
affected hemisphere: the basal ganglia level, which 
includes the caudate, insula, internal capsule, 
lentiform, and M1-M3, and the supraganglionic 
level, which includes M4-M6. For each of the 
defined regions, a single point is subtracted for 
an area of early ischaemic damage, such as loss 
of grey—white matter interface, focal swelling, 
and parenchymal hypoattenuation. Parenchymal 
hypoattenuation is defined as a region of 
abnormally decreased attenuation of brain 
structures relative to attenuation of other parts of 
the same structures or of the contralateral 
hemisphere. Focal brain swelling or mass effect is 
defined as any focal narrowing of the cerebrospinal 
fluid space due to compression by adjacent 
structures, such as ventricular compression or 
effacement of cortical sulci. An ASPECTS score of 
zero indicates diffuse ischaemic damage. A normal 
CT scan is assigned an ASPECTS score of ten.
Clinical Validation of the ASPECTS Score as a 
Selection Tool for Intravenous Thrombolysis
The ASPECTS score is recommended by the 
American Society of Neuroradiology17 and was 
shown to be a reliable and strong predictor 
of functional outcome and sICH following 
thrombolytic treatment.10,16,18,19 Clinical studies have 
demonstrated that patients with an ASPECTS score 
>7 were most likely to benefit from treatment,18 while 
those scoring <5 were unlikely to see any improved 
outcome and were exposed to a significantly 
higher risk of sICH following thrombolysis.20
Clinical Validation of the ASPECTS Score as a 
Selection Tool for Endovascular Treatment
The most relevant study regarding ASPECTS as a 
selection tool for endovascular stroke treatment 
is the ESCAPE trial.21 Patients were selected for 
treatment by a pre-specified ASPECTS range of 
6-10, thereby identifying patients with a small 
infarct core. In the majority of other trials, 
ASPECTS has been applied post-hoc, which is of 
far less clinical significance. In the Interventional 
Management of Stroke (IMS-1) study, patients with 
an ASPECTS score >7 were more likely to benefit 
from the combined IV-intra-arterial (IA) approach 
than from IV rt-PA alone (based on matched 
patients from the National Institute of Neurological 
Disorders and Stroke rt-PA study ASPECTS 
analysis), with the number needed to treat at ten.22 
Patients with an ASPECTS score of <8 were less 
likely to benefit from combined IV-IA than from 
IV thrombolysis, and more likely to be harmed 
by interventional therapy. Overall, these data are 
evidence of both a qualitative and quantitative 
interaction effect with ASPECTS.
AUTOMATION OF BRAIN COMPUTED
TOMOGRAPHY ANALYSIS
Recently a new software, e-ASPECTS (Brainomix 
Ltd., Oxford, UK), for automated detection of 
acute ischaemic stroke using the validated ASPECTS 
score was introduced.23 An independent clinical 
validation study was conducted by Anglia Ruskin 
University comparing the performance of the 
software with expert neuroradiologists. The aim 
of this study was to demonstrate that e-ASPECTS 
is non-inferior to experienced neuroradiologists. 
The CE-marked e-ASPECTS software has been 
developed to automate the ASPECTS scoring 
system for ischaemic stroke patients. The algorithm 
processes brain CT scans in a similar way to a 
human expert, applying the ASPECTS score. It takes 
non-contrast brain CT scans as input; the patient’s 
brain is registered to an atlas so that anatomical 
features of the brain can be recognised and the 
ASPECTS regions segmented from the 3D data set. 
A scoring module then looks at each region for 
signs of ischaemic damage, and the ASPECTS score 
is generated with a report detailing the overall 
ASPECTS score, as well as which regions were 
found to contain ischaemic damage (Figure 1). 
There is overall agreement in the literature that a 
standardised, independent, and automated CT 
assessment tool is needed and could positively 
impact patient care, although all other publications 
identified present technologies that have been 
developed in a research environment with no 
intention for clinical use. 
The first approach to automate stroke detection 
on CT scans simply compared the whole left-hand 
side of a brain CT scan with the right-hand side.24 
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The proposed method consisted of image 
enhancement, detection of midline symmetry, 
and classification of abnormal slices. A windowing 
operation was performed on the intensity 
distribution to enhance the region of interest. 
A two-level classification scheme was used to 
detect abnormalities using features derived in the 
intensity and the wavelet domain. The proposed 
method was evaluated on a limited dataset of 
15 patients, giving 90% accuracy and 100% recall 
in detecting abnormality at patient level. Average 
precision of 91% and recall of 90% at the slice level 
was described. The surprisingly high sensitivity 
and specificity on this small dataset possibly 
indicates over-fitting. 
Tang et al.25 proposed a novel ‘circular adaptive 
region of interest’ method to analyse CT images 
of the brain. Results indicated that for emergency 
physicians and radiology residents there was 
a significant improvement in sensitivity and 
specificity when using computer-aided detection 
(p<0.005). The authors used an image-feature 
approach for computer-aided detection of 
ischaemic stroke with well-described results. 
Compared with e-ASPECTS the approach was 
limited to detection of stroke versus no detection, i.e. 
there is no consideration of the extent of damage. 
Boers et al.26 used a semi-automated delineation 
of follow-up CT scans. The cerebral infarct volumes 
of 34 consecutive patients were segmented with 
an automated, intensity-based, region-growing 
algorithm, which included partial volume effect 
correction near the skull, midline determination, 
and ventricle and haemorrhage exclusion. 
Damage was assessed based on a seed point 
selected by a radiologist, thus not addressing the 
subtle, early ischaemic changes that e-ASPECTS 
looks for. The Pearson correlation for the 
automated method compared with the reference 
standard was similar to the manual correlation 
(R=0.98). The accuracy of the automated method 
had a mean difference of 0.5 ml with limits of 
agreement of -38.0-39.1 ml, which were more 
consistent than the inter-observer variability of the 
two observers (-40.9-44.1 ml). However, the Dice 
coefficients were higher for the manual delineation. 
The performance was very slow with the technique 
apparently taking 2 hours per scan.
Figure 1: Automated scoring output of the electronic Alberta Stroke Program Early CT Score 
(e-ASPECTS) web interface. 
There is fresh ischaemic damage in the left caudate and lentiform. The ASPECTS score is 8. 
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Rajini et al.27 looked for small infarcts (e.g. lacunes) 
only. The proposed method consists of pre-
processing, segmentation, tracing the midline of 
the brain, extraction of texture features, and 
classification. The application improved efficiency 
and accuracy of clinical practice with an average 
overlap metric, average precision, and average 
recall between the results obtained to the ground 
truth of 0.98, 0.99, and 0.98, respectively. From 
the publication it was not clear if the authors had 
separate training and test sets. The algorithm 
only tested for the presence or absence of 
damage on a per-slice basis. The authors only 
tested a small dataset with the results probably 
indicating over-fitting.
Bentley et al.28 evaluated a tool for prediction of 
sICH following thrombolysis. CT images acted as 
input into a support vector machine (SVM), along 
with non-image features (specifically NIHSS score). 
Predictive performance compared favourably with 
that of prognostic scores (original and adapted 
versions: 0.626-0.720; p<0.01). The SVM also 
identified 9 out of 16 sICHs as opposed to 1-5 using 
prognostic scores, assuming a 10% sICH frequency 
(p<0.001). The dataset appears to be of an 
adequately high number (n=106), but the algorithm 
was only tested via cross-validation, which can 
lead to over-fitting. The authors acknowledged 
that they could improve their image analysis by 
using image features rather than all the voxels, 
which is what e-ASPECTS does with a variety of 
image features.
Przelaskowski et al.29 described a system for image 
enhancement to improve interpretation by the 
human eye. The system defines a ‘stroke window’ 
that adjusts the contrast of the image to better 
show hypodense areas. They did not automate 
the actual detection of damage, that is left to 
radiologists, but the publication does demonstrate 
that radiologists performed better when looking at 
their system. 
Shieh et al.30 developed an automatic ASPECTS 
scoring system using contralateral comparison. 
Receiver operating characteristic analysis based 
on evaluation of 103 patients with symptoms of 
acute stroke showed that the system’s dichromatic 
classification of patients into thrombolysis- 
indicated or thrombolysis-contraindicated groups 
achieved a high accuracy, with area under curve 
equal to 90.2%. The average processing time for a 
single case was 170 seconds. 
CONCLUSION
This literature review underlines the need for 
standardised image interpretation to identify 
appropriate treatment options in acute stroke 
management that translate into clinical benefits 
for patients. Imaging of the brain parenchyma is a 
composite surrogate for time elapsed from stroke 
onset and collateral status, as well as severity of 
ischaemia and extent of thrombus. However, it must 
be remembered that imaging is only one factor 
in a complex equation. Even expert physicians in 
current practice will often not agree on treatment 
decisions. As such, they will never use ASPECTS 
or e-ASPECTS in isolation, but will use it as 
complementary information.
In the hyperacute setting, ASPECTS has been 
validated as a predictor of functional outcome in 
acute ischaemic stroke patients receiving IV 
alteplase and endovascular treatment. Therefore, 
integration of the ASPECTS score into a clinical 
care pathway as a decision-support tool would be 
reasonable. However, the required expertise that 
the manual application of ASPECTS carries can 
limit its use in clinical care. In addition, intra and 
inter-observer variability is an issue not only in 
the clinical environment but also in clinical trial 
enrolment when using image selection criteria. 
The development of the e-ASPECTS software 
enables fast and standardised assessment of the 
brain CT scan using the validated ASPECTS score 
irrespective of the expertise of the interpreter, thus 
eliminating inter and intra-observer variability. It 
will be of great value to assess how standardised 
use of ASPECTS translates into long-term 
outcomes that are meaningful to patients in terms 
of overall health status, functional ability, cognition, 
and quality of life. 
The conclusions about the performance and safety 
of ASPECTS outlined in this literature review are 
intended to represent the consensus of a global 
forum of stroke experts, and to provide a 
framework for the assessment of acute stroke 
care provision, using the CE-marked, standardised 
software e-ASPECTS, with regard to access to 
care and patient outcomes in both the hyperacute 
and acute hospital setting, as well as in clinical 
trial enrolment. The e-ASPECTS non-inferiority 
study will provide the necessary evidence 
to demonstrate the reliable performance of 
e-ASPECTS in a clinical setting. 
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